Hydrolases TRIZ Cases

Replacing Argonaute nucleases with Cas13 endonuclease eliminates seed region bias, enabling specific nuclear RNA knockdown without off-target cleavage.

A ClvR gene drive system uses Cas9 and a rescue transgene to modify plant populations.

A Caspase-ER(T2) fusion protein enables ligand-mediated apoptosis induction across diverse mammalian cell types.

Stratifying PDAC patients by stromal subtype to apply targeted DDR1 or NRF2 inhibition, resolving treatment variability caused by conflicting stromal roles.

This assay resolves the trade-off between detection sensitivity and infrastructure complexity by using isothermal amplification and collateral enzyme activity.

Genetically modified animal primary cells amplify to form meat tissue, reducing greenhouse gas emissions and virus transmission risks.

A transgenic mouse model expressing the iBox peptide inhibitor enables precise evaluation of Group B p21-activated kinase roles in development and disease.

Engineered yeast strains redirect NADH oxidation to eliminate glycerol formation, boosting ethanol yield and reducing wastewater treatment costs.

NHEJ inhibitors paired with promoter trapping enhance homologous recombination efficiency for direct genome cloning.

Mutant RNase H2 enzymes cleave RNA strands in emulsion droplets, resolving primer dimer formation and boosting quantification accuracy.

Direct bombardment of mature seed or bud shoot apices eliminates tissue culture requirements and somatic mutations while ensuring transgene transmission.

TALENs replace random integration with targeted cleavage, eliminating unintended genomic changes and reducing time required for modification.

Tandem mass spectrometry detects PPT1 and TPP1 enzyme activity using specific substrates and internal standards in dried blood spots.

Targeting p97 ATPase activity overcomes proteasome inhibitor limitations in solid tumors.

Modular genetic cassettes resolve complexity bottlenecks by enabling scalable spatiotemporal regulation of multiple genes.

Segmenting the replication protein into the WH1 domain enables X-ray crystallography to resolve structural details, facilitating rational drug discovery.

TteAgo enables site-specific genetic modification in mammalian cells, resolving the lack of documented eukaryotic DNA cleavage activity.

Engineered microorganisms produce poly(hydroxyisobutyric acid) from feedstocks using CoA-ligases and PHA polymerases.

Loss of function in sulfolipid biosynthesis genes UGP3, SQD1, and SQD2 confers non-transgenic resistance to oxyfluorfen herbicide.

Guide nucleic acids direct nuclease complexes to safe genomic sites, preventing random integration near proto-oncogenes and avoiding malignant transformation.

Extracting hemicellulose for fermentation reduces enzyme costs.

Modified guide RNA molecules incorporate a 5' cap structure and a 3' polyA tail to enhance stability against degradation in eukaryotic cells.

Hypertonic medium treatment reduces turgor pressure in monocot meristem tissue for direct biolistic transformation.

Drug-inducible transposase systems calibrate gene amplification at safe harbor loci, reducing clonal selection time to three days.

Enzymatic resolution with base-mediated racemization recycles unwanted enantiomers, resolving yield-purity trade-offs in pregabalin synthesis.

Genetically engineered GDSL lipase catalyzes esterification to produce vitamin A palmitate.

Specific amino acid mutations in restriction endonucleases reduce star activity and improve DNA cleavage specificity under non-optimal buffer conditions.

Self-targeting guide RNAs direct DNA binding proteins to suppress over-amplified sequences, reversing PCR bias and preserving library diversity.

A lyophilized multi-enzyme cocktail digests nucleic acids into individual nucleosides for liquid chromatography tandem mass spectrometry analysis.

Structurally stable cyanuric acid hydrolase degrades excess cyanuric acid in situ, preventing chlorine-lock without draining pool water.

Alpha/beta hydrolases cleave ergopeptin cyclol rings to produce less toxic metabolites, resolving livestock toxicity issues in feed applications.

Cas9-gRNA complexes cleave nucleic acids and protect targets from exonuclease digestion, eliminating amplification bias and simplifying library preparation.

Disassembling and reassembling JCV-derived virus-like particles into pentamers increases cargo loading capacity while maintaining stability during storage.

Adding phosphorous compounds to RNA solutions prevents autocatalytic degradation during elevated temperature incubation with divalent cations.

Pool-and-split multiplexing with barcoded adapters enables quantitative ChIP-seq comparison across cell types without separate immunoprecipitation steps.

Deleting AbrB-like transcriptional regulators and acyl-ACP synthetase functions boosts fatty acid secretion per cell, resolving low biofuel productivity.

A polyurethane cleaving process uses alcoholysis to separate solid carbamates from liquid polyol phases.

Deleting inhibitory endogenous loci boosts transformation efficiency 10,000-fold for metabolic engineering chassis.

Tributanoylated hexosamines increase sialylation uniformity and half-life while reducing cytotoxicity compared to perbutanoylated derivatives.

Mutant CPC acylase converts cephalosporin C directly to 7-aminocephalosporanic acid, eliminating hydrogen peroxide damage from intermediate steps.

Engineered cytidine deaminase variants convert unmethylated cytosines to uracils, avoiding DNA fragmentation from chemical bisulfite treatment.